The following funding opportunities are specific to COVID-19. The list will be updated as new opportunities arise.

Sponsor Program Amount  Deadline 
Amazon Web Services (AWS) AWS Diagnostic Development Initiative (DDI) AWS Promotional Credits and Technical Expertise 7/31/2021
National Institutes of Health (NIH) NIAAA SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) $750,000 (direct costs) 8/17/2021
National Institutes of Health (NIH) NIAAA SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) $100,000 (direct costs) 8/17/2021
National Institutes of Health (NIH) NIAAA SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed $275,000 (direct costs) 8/17/2021
National Institutes of Health (NIH) NIAAA Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed)  $250,000 (direct costs) 9/1/2021
National Institutes of Health (NIH) NIAAA Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed) $50,000 (direct costs) 9/1/2021
National Institutes of Health (NIH) NIAAA Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) $150,000 (direct costs) 9/1/2021
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection Varies (see RFAs within) 1/4/2021 (applications accepted through 9/8/2024)
National Institutes of Health (NIH) NIMH Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research Varies 1/5/2021 (applications accepted through 6/1/2023)
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection Varies (see RFAs within) 1/7/2021 (subsequent receipt dates through 9/8/2024)
National Institutes of Health (NIH) NIMHD, NIA, NIDA, NCI Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Not limited 10/5/2020 (and standard R01 deadlines)
National Institutes of Health (NIH) NIMHD, NIAMS, NIDA, NIMH, NLM, NCI Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities Must reflect your needs 10/5/2020 (subsequent receipt dates through 5/8/2023)
National Institutes of Health (NIH) NICHD Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract Must reflect your needs 10/5/2020 (subsequent receipt dates through 7/16/2023)
National Institutes of Health (NIH) NHLBI Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) Must reflect your needs 10/5/2020 (subsequent receipt dates through 7/5/2024)
National Institutes of Health (NIH) NIDCD Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders Varies (see RFAs within) 10/5/2020 (subsequent receipt dates through 9/8/2022)
National Institutes of Health (NIH) NIMHD, NIAAA, NIDA Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) Must reflect your needs 11/27/2020 (subsequent receipt dates within RFA)
National Institutes of Health (NIH) NIAMS Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases Varies (see RFAs within) 2/5/2021 (subsequent receipt dates through 11/18/2021)
National Institutes of Health (NIH) NICHD Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic Must reflect your needs 2/5/2021 (subsequent receipt dates through 5/8/2023)
Department of Energy (DOE) Invitation for COVID-19 Scientific questions DOE Resources 3/18/2020 (reviews start 3/18 but accepted on a rolling basis)
National Institutes of Health (NIH) NIA Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) Varies (see RFAs within) 3/4/2021 (applications accepted through 5/8/2023)
National Institutes of Health (NIH) NIEHS Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 5/1/2020, 6/1/2020 (other deadlines within)
National Institutes of Health (NIH) NIAID, NIA Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to amount of current parent 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to no more than 25% total costs of the amount of the current parent award 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH) NIAAA Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA $200,000 (direct costs) 5/15/2020 (applications accepted until 4/15/2021)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Check RFA(s) within 6/5/2020 (other later deadlines within)
National Institutes of Health (NIH) NIDCR Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) Varies (see RFAs within) 6/5/2021 (subsequent receipt dates through 5/8/2023)
National Institutes of Health (NIH) NICHD Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth Varies (see RFAs within) 6/5/2021 (subsequent receipt dates through 5/8/2024)
National Institutes of Health (NIH) NIA, NEI, NIAAA, NIDA, NIMH, NIMHD (OBSSR, ORWH) Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) $2,500,000 (direct costs) 6/9/2021 and 11/8/2021
National Institutes of Health (NIH) NIA NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Must reflect your needs 7/1/2020; 8/3/2020; and others
National Institutes of Health (NIH) OD, NHLBI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHD, NCCIH, NCATS, ORIP, NCI Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project $1,000,000 (direct costs) 7/13/2020; 11/12/2020; other deadlines within
National Institutes of Health (NIH) NIAID Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2   9/14/2020; 10/14/2020; 11/14/2020 (other deadlines within)
Merck KGaA (Germany) Research Grant for Pandemic Preparedness 1,500,000 Euros Applications accepted on a rolling basis
Mozilla COVID-19 Solutions Fund $50,000 Applications accepted on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards $150,000 Applications accepted on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects $500,000 Applications accepted on a rolling basis
National Institutes of Health (NIH)

NIAID

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Budgets should reflect actual needs (direct costs only) Applications accepted until 7/8/2021
National Science Foundation (NSF) RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 Check with program officers
COVID-19 Early Treatment Fund (CETF) Funding for Outpatient Trials Up to $1M Currently accepting applications
The Greenwall Foundation Making a Difference in Real-World Bioethics Dilemma Not specified LOI: 6/28/2021; Full Proposal: 9/2/2021
National Institutes of Health (NIH) NIBIB Point-of-Care Technology Research Network (POCTRN) Fast-Track Program for COVID-19 Test Development and Distribution) Phase 0: $25,000 Rolling (selection process began 4/29/2020)
Coalition for Epidemic Preparedness Innovations (CEPI) Expression of Interest: Vaccine Drug Products in alternative primary packaging and delivery devices Not specified Rolling basis
Coalition for Epidemic Preparedness Innovations (CEPI) CEPI partner NIBSC is seeking partners for sourcing serum or plasma from individuals recovered from infection with SARS-CoV-2 variants for the development of antibody working standards and reference panels Serum/plasma collection and shipment expenses will be fully covered Rolling basis
Comcast Innovation Fund Innovation Fund Grants Area of Interest 2021: COVID-19 Effects on the Internet $150,000 Rolling basis as long as funding is available
National Institutes of Health (NIH) NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB,NCATS Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Not limited See Emergency Notice of Special Interest by IC
Cisco Pandemic/COVID-19 Science, Technology and Social Impact Unspecified  Unspecified 
Autism Speaks COVID-19 Call for Resources N/A Unspecified 
Draper Richards Kaplan Foundation EWDRK Covid-19 Urgent Response Initiative (CURI) $50,000-$100,000 (CURI invests 25% maximum of total) Unspecified 
Biogen Foundation (typically funds Boston, MA & Research Triangle,NC) COVID-19 Response Unspecified (up to $10M in total funding) Unspecified (accepting applications)
National Institutes of Health (NIH) NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCH, NCI Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) Must reflect your needs Varies by awarding IC